These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24421483)

  • 1. Continuing education case study quiz.
    Hosp Pharm; 2013 Apr; 48(4):332-3. PubMed ID: 24421483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuing education case study quiz.
    Hosp Pharm; 2013 Mar; 48(3):241-2. PubMed ID: 24421468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuing education case study quiz.
    Hosp Pharm; 2013 Feb; 48(2):153-5. PubMed ID: 24550570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuing Education Case Study Quiz.
    Hosp Pharm; 2016 Mar; 51(3):263-265. PubMed ID: 38745582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuing education case study quiz.
    Hosp Pharm; 2013 Jan; 48(1):57-9. PubMed ID: 24550569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical pharmacology profile of the new antiepileptic drug perampanel: A novel noncompetitive AMPA receptor antagonist.
    Patsalos PN
    Epilepsia; 2015 Jan; 56(1):12-27. PubMed ID: 25495693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of enzyme inhibition on perampanel pharmacokinetics: Why study design matters.
    Gidal BE; Maganti R; Laurenza A; Yang H; Verbel DA; Schuck E; Ferry J
    Epilepsy Res; 2017 Aug; 134():41-48. PubMed ID: 28535410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The practical impact of altered dosing on perampanel plasma concentrations: pharmacokinetic modeling from clinical studies.
    Gidal BE; Majid O; Ferry J; Hussein Z; Yang H; Zhu J; Fain R; Laurenza A
    Epilepsy Behav; 2014 Jun; 35():6-12. PubMed ID: 24785428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perampanel Pharmacokinetics in Children: Correlation of Dose With Serum Concentrations.
    Gaudio E; Gienapp AJ; Wheless J
    J Child Neurol; 2019 Jul; 34(8):427-431. PubMed ID: 30909831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perampanel: a new agent for adjunctive treatment of partial seizures.
    Faulkner MA
    Am J Health Syst Pharm; 2014 Feb; 71(3):191-8. PubMed ID: 24429011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Inflammation on the Pharmacokinetics of Perampanel.
    Yamamoto Y; Takahashi Y; Horino A; Usui N; Nishida T; Imai K; Kagawa Y; Inoue Y
    Ther Drug Monit; 2018 Dec; 40(6):725-729. PubMed ID: 30086086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration-effect relationships with perampanel in patients with pharmacoresistant partial-onset seizures.
    Gidal BE; Ferry J; Majid O; Hussein Z
    Epilepsia; 2013 Aug; 54(8):1490-7. PubMed ID: 23772853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, exposure-cognition, and exposure-efficacy relationships of perampanel in adolescents with inadequately controlled partial-onset seizures.
    Villanueva V; Majid O; Nabangchang C; Yang H; Laurenza A; Ferry J; Hussein Z
    Epilepsy Res; 2016 Nov; 127():126-134. PubMed ID: 27595590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of pooled phase III trials of adjunctive perampanel for epilepsy: Impact of mechanism of action and pharmacokinetics on clinical outcomes.
    Kwan P; Brodie MJ; Laurenza A; FitzGibbon H; Gidal BE
    Epilepsy Res; 2015 Nov; 117():117-24. PubMed ID: 26448264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic/pharmacodynamic analysis of adjunctive perampanel in subjects with partial-onset seizures.
    Takenaka O; Ferry J; Saeki K; Laurenza A
    Acta Neurol Scand; 2018 Apr; 137(4):400-408. PubMed ID: 29171002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, tolerability, and clinical effectiveness of perampanel in Japanese patients with epilepsy.
    Yamamoto Y; Shiratani Y; Asai S; Usui N; Nishida T; Imai K; Kagawa Y; Takahashi Y
    Seizure; 2020 Dec; 83():181-186. PubMed ID: 33171342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of perampanel in young children with drug-resistant epilepsy.
    Chang FM; Fan PC; Weng WC; Chang CH; Lee WT
    Seizure; 2020 Feb; 75():82-86. PubMed ID: 31901668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland.
    Väätäinen S; Soini E; Peltola J; Charokopou M; Taiha M; Kälviäinen R
    Adv Ther; 2020 Jan; 37(1):477-500. PubMed ID: 31808053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of perampanel on pharmacokinetics of concomitant antiepileptics in patients with partial-onset seizures: pooled analysis of clinical trials.
    Majid O; Laurenza A; Ferry J; Hussein Z
    Br J Clin Pharmacol; 2016 Aug; 82(2):422-30. PubMed ID: 27038098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post-hoc analysis.
    Glauser T; Laurenza A; Yang H; Williams B; Ma T; Fain R
    Epilepsy Res; 2016 Jan; 119():34-40. PubMed ID: 26656783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.